Brain Connectivity Findings in Cannabis Tolerance Are Not an Individual Impairment Test

A small controlled cannabis study linked altered brain signals with attention and subjective effects. It offers evidence about possible tolerance mechanisms, but did not validate a brain scan that can classify an individual as impaired or unimpaired.

Two use-history groups received cannabis and placebo

The experiment included 12 occasional and 12 chronic cannabis users. Each received cannabis containing 300 micrograms THC per kilogram and placebo on separate study days. Researchers used functional MRI, magnetic resonance spectroscopy, a psychomotor vigilance task and subjective ratings. Cannabinoids were measured in serum, which should not be relabeled as whole blood.

The treatment comparison was controlled, but prior cannabis-use history was not randomly assigned. A comparison of chronic and occasional users therefore cannot exclude every pre-existing group difference.

The imaging results were specific

In occasional users, cannabis reduced functional connectivity involving reward-system regions and increased striatal glutamate relative to total creatine. Comparable significant treatment effects were not found in chronic users. Other findings differed by metabolite and brain region; the results do not describe a uniform shutdown or activation of the entire brain.

Cannabis increased subjective high in both groups, more strongly among occasional users. Follow-up attention analyses found slower responses and more lapses among occasional users, while these outcomes were nonsignificant among chronic users. Preserved performance on this task does not establish normal performance in every cognitive domain.

A mechanism is different from a diagnostic rule

Functional connectivity measures relationships between imaging signals. Its interpretation as evidence about dopamine transmission was indirect; the scan did not directly measure dopamine release. Correlations between selected imaging changes and behavior also do not show that the imaging change caused the behavioral effect.

The study did not report a validated individual diagnostic threshold, prospective classification performance or on-road driving test. With only 24 participants and numerous imaging and behavioral outcomes, replication and careful handling of multiple comparisons remain important.

The useful inference is a research hypothesis: repeated exposure may change responsiveness in particular neural systems. A forensic conclusion still needs evidence connecting the relevant function, timing and exposure to the individual event.

Related analysis: evaluating cannabis tolerance claims.

Primary research

Mason NL; Theunissen EL; Hutten NRPW; Tse DHY; Toennes SW; Jansen JFA; Stiers P; Ramaekers JG. Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users. Addiction biology (2021). DOI: 10.1111/adb.12870.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Less Vomiting With CBD Did Not Mean Protection From THC’s Cognitive Effects in Primates

Adding CBD was associated with less first-day vomiting in a small adolescent-primate experiment, but did not prevent the measured THC-related learning disruption. Improvement in one adverse outcome should not be presented as general protection. Three small treatment groups Twelve male squirrel monkeys received vehicle, THC alone or THC with CBD,…

Spread the love

Read Article: Less Vomiting With CBD Did Not Mean Protection From THC’s Cognitive Effects in Primates

A Receptor Mutation Did Not Delay THC Tolerance in a Chemotherapy-Neuropathy Model

A cannabinoid-receptor mutation associated with altered tolerance in other experiments did not delay THC tolerance in mice with cisplatin-related neuropathy. The result shows why a mechanism demonstrated in one pain model may not transfer to another. A chronic pain model with two sexes Researchers studied wild-type mice and animals carrying…

Spread the love

Read Article: A Receptor Mutation Did Not Delay THC Tolerance in a Chemotherapy-Neuropathy Model

Mouse Cannabinoid Withdrawal Findings Depended on Timing and Agonist Efficacy

Behavior after cannabinoid cessation differed with the compound, dose and observation time in a mouse study. An early negative assessment could miss later changes, while a strong response to a synthetic agonist should not be relabeled as a THC result. Continuous observation added information Researchers compared repeated THC with AM2389,…

Spread the love

Read Article: Mouse Cannabinoid Withdrawal Findings Depended on Timing and Agonist Efficacy

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us